Welcome to Elicera's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders.

If you need more information or have any questions, please contact Jamal El-Mosleh, CEO.

Phone: +46(0)703 31 90 51

Press Releases

January 11, 2021
Elicera Therapeutics recruits CFO
Read more
January 8, 2021
Elicera Therapeutics invitation to company presentation (in Swedish)
Read more
October 4, 2020
Elicera Therapeutics completes oversubscribed share issue and launches unique immuno-oncology company with focus on CAR T-cells and oncolytic viruses
Read more
All Press Releases

Corporate Governance

The following sections contain information that are relevant for Elicera's corporate governance.

Articles of AssociationGeneral MeetingBoardManagement

Financial Reports

Financial Calendar

See the calendar